Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Measles vaccines—A positive step toward eradicating a negative strand

Measles is the leading cause of vaccine-preventable deaths among children worldwide. The development of a measles DNA vaccine may prevent the complications associated with non-infectious vaccine approaches and eventually contribute to global measles eradication (pages 776–781 ).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Vaccine-induced measles immunity.

Bob Crimi

References

  1. Murray, C.J.L. & Lopez, A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349, 1269–1276 (1997).

    Article  CAS  Google Scholar 

  2. Redd, S.C., Markowitz, L.E. & Katz, S.L. in Vaccines 3rd edn. (eds. Plotkin, S.A. & Ornstein, W.A.) 22–266 (W.B. Saunders, Philadelphia, 1999).

    Google Scholar 

  3. deQuadros, C.A. et al. Measles elimination in the Americas: Evolving strategies. J. Am. Med. Assoc. 275, 224–229. (1996).

    Article  CAS  Google Scholar 

  4. Gans, H.A. et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. J. Am. Med. Assoc. 280, 527–532 (1998).

    Article  CAS  Google Scholar 

  5. Polack, F. P. et al. Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nature Med. 6, 776–781 ( 2000).

    Article  CAS  Google Scholar 

  6. Tamin, A. et al. Antigenic analysis of current wild type and vaccine strains of measles virus. J. Infect. Dis. 170, 795– 801 (1994).

    Article  CAS  Google Scholar 

  7. Polack, F.P. et al. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nature Med. 5, 629–634 (1999).

    Article  CAS  Google Scholar 

  8. Gans, H.A. et al. IL-12, IFN-γ and T cell proliferation to measles in immunized infants. J. Immunol. 162, 5569– 5575 (1999).

    CAS  PubMed  Google Scholar 

  9. van Binnendijk, R.S., Poelen, M.C., van Amerongen, G., deVries, P. & Osterhaus, AD. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J. Infect. Dis. 175, 524–532( 1997).

    Article  CAS  Google Scholar 

  10. Liu, M.A., Fu, T-M., Donnelly, J.J., Caulfield, M.J. & Ulmer, J.B. DNA vaccines: mechanisms for generation of immune responses. Adv. Exp. Med. Biol. 452, 187 –191 (1998).

    Article  CAS  Google Scholar 

  11. Rodriquez, F & Whitton, J.L. Enhancing DNA immunization. Virology 268, 233–238 ( 2000).

    Article  Google Scholar 

  12. Seigrist, C-A. et al. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime boost strategies in mice. Eur. J. Immunol. 28, 4138– 4148 (1998).

    Article  Google Scholar 

  13. Wang, Y., Xiang, Z., Pasquini, S. & Ertl, H.C. Immune response to neonatal genetic immunization. Virology 228, 278–284 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arvin, A. Measles vaccines—A positive step toward eradicating a negative strand. Nat Med 6, 744–745 (2000). https://doi.org/10.1038/77462

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/77462

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing